NeuroSense Therapeutics Ltd. (NRSN): Total Liabilities
$2.59M
As of 2025-12-31
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.59M | +29.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.99M | -59.7% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $4.94M | n/a | 2025-04-07, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) | 2025-12-31 | $2.59M | +29.9% |
| Ocean Biomedical, Inc. (OCEA) | 2024-12-31 | $98.52M | n/a |
| Aspire-Lakewood Holdings, Inc. (ASBP) | 2025-12-31 | $7.69M | +355.5% |
| Semnur Pharmaceuticals, Inc. (SMNR) | 2025-12-31 | $22.10M | -55.3% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $7.00M | +0.4% |
| Accustem Sciences Inc. (ACUT) | 2025-12-31 | $4.95M | +47.2% |
| Bioxytran, Inc (BIXT) | 2025-12-31 | $3.25M | +68.3% |
| Alzamend Neuro, Inc. (ALZN) | 2026-04-30 | $1.35M | +112.1% |
| Bio Essence Corp (BIOE) | 2025-12-31 | $2.50M | -23.2% |
Compare NRSN, OCEA, ASBP, SMNR side by side · Screen every company in Pharmaceutical Preparations ↗